Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats

Adachi, 1995, Design, synthesis and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720, Bioorg. Med. Chem. Lett., 5, 853, 10.1016/0960-894X(95)00127-F

Badger, 1993, Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression, Int. J. Immunopharmac., 15, 343, 10.1016/0192-0561(93)90045-Z

Banerjee, 1992, The induction of arthritis in mice by the cartilage proteoglycan aggrecan: role of CD4+ and CD8+ T cells, Cell. Immunol., 144, 347, 10.1016/0008-8749(92)90250-S

Billingham, 1990, Monoclonal antibodies and arthritis, Agents Actions, 29, 77, 10.1007/BF01964727

Bradbeer, 1996, Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis, Arthritis Rheum., 39, 504, 10.1002/art.1780390319

Cannon, 1990, Effects of indomethacin, cyclosporin, cyclophosphamide and placebo on collagen-induced arthritis of mice, Agents Actions, 29, 315, 10.1007/BF01966463

Chiba, 1996, FTY720, a novel immunosuppressant possessing unique mechanisms. I. prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats, Transplant Proc., 28, 1056

Chiba, 1998, FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing, J. Immunol., 160, 5037, 10.4049/jimmunol.160.10.5037

Chu, 1996, Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs, J. Immunol., 157, 2685, 10.4049/jimmunol.157.6.2685

Day RO, Graham, GG, Williams KM, Champion GD, Jager J. Clinical pharmacology of non-steroidal anti-inflammatory drugs. In: Orme MCL’E, editor. Anti-rheumatic drugs. New York: Pergamon Press. 1990:137–87

Engelhardt, 1995, Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat, Inflamm. Res., 44, 548, 10.1007/BF01757360

Engvall, 1972, Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes, J. Immunol., 109, 129, 10.4049/jimmunol.109.1.129

Franch, 1994, Blood lymphocyte subsets in rats with adjuvant arthritis, Ann. Rhum. Dis., 53, 461, 10.1136/ard.53.7.461

Fujita, 1994, Fungal metabolites. Part 11. a potent immunosuppressive activity found in Isaria sinclairii metabolite, J. Antibiot., 47, 208, 10.7164/antibiotics.47.208

Gao, 1993, The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis, Int. J. Immunopharmac., 15, 793, 10.1016/0192-0561(93)90016-R

Gao, 1994, The effect of ebselen on T-lymphocyte migration to arthritic joints and dermal inflammatory reaction in the rat, Int. J. Immunopharmac., 16, 279, 10.1016/0192-0561(94)90002-7

Hoshino, 1996, FTY720, a novel immunosuppressant possessing unique mechanisms. II. long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A, Transplant Proc., 28, 1060

Kameda, 1996, Effect of mizoribine on collagen-induced arthritis in mice, Jpn. J. Pharmacol., 70, 169, 10.1254/jjp.70.169

Kirwan, 1995, The effect of glucocorticoids on joint destruction in rheumatoid arthritis, N. Engl. J. Med., 333, 142, 10.1056/NEJM199507203330302

Littler TR. Anti-rheumatic drugs. In: Orme MCL’E, editor. Anti-rheumatic drugs. New York: Pergamon Press, 1990:189–216

Masubuchi, 1996, FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft vs host reactions in rats, Transplant Proc., 28, 1064

Pelegri, 1995, Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25, Cell. Immunol., 165, 177, 10.1006/cimm.1995.1203

Popp, 1994, Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis, Agents Actions, 42, 50, 10.1007/BF02014300

Sasaki, 1994, Fungal metabolites. Part 14. novel potent immunosuppressants, mycestericins, produced by Mycelia sterilia, J. Antibiot., 47, 420, 10.7164/antibiotics.47.420

Shiokawa, 1991, Clinical effectiveness of mizoribine on rheumatoid arthritis: A double-blind comparative study using lobenzarit disodium as a standard drug, Jpn. J. Inflamm., 11, 375

Suzuki, 1997, The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720, Clin. Exp. Immunol., 107, 103, 10.1046/j.1365-2249.1997.d01-885.x

Weichman, 1987, Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats:evidence for reversal of joint damage, Arthritis Rheum., 30, 466, 10.1002/art.1780300419